These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34253777)

  • 41. Combination therapy for refractory idiopathic thrombocytopenic purpura in adolescents.
    Williams JA; Boxer LA
    J Pediatr Hematol Oncol; 2003 Mar; 25(3):232-5. PubMed ID: 12621242
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low-dose versus high-dose immunoglobulin for primary treatment of acute immune thrombocytopenic purpura in children: results of a prospective, randomized single-center trial.
    Benesch M; Kerbl R; Lackner H; Berghold A; Schwinger W; Triebl-Roth K; Urban C
    J Pediatr Hematol Oncol; 2003 Oct; 25(10):797-800. PubMed ID: 14528103
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Different dosages of intravenous immunoglobulin (IVIg) in treating immune thrombocytopenia with long-term follow-up of three years: Results of a prospective study including 167 cases.
    Zhou Z; Qiao Z; Li H; Luo N; Zhang X; Xue F; Yang R
    Autoimmunity; 2016; 49(1):50-7. PubMed ID: 26525513
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Idiopathic thrombocytopenic purpura in childhood: a 10-year audit.
    Paling A; Stefan DC
    Hematology; 2008 Jun; 13(3):175-80. PubMed ID: 18702876
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A proposal for new definition (s) and management approach to paediatric refractory ITP: Reflections from the Intercontinental ITP Study Group.
    Neunert C; Heitink-Polle KMJ; Lambert MP
    Br J Haematol; 2023 Oct; 203(1):17-22. PubMed ID: 37641973
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intracranial hemorrhage in immune thrombocytopenic purpura: a retrospective analysis.
    Butros LJ; Bussel JB
    J Pediatr Hematol Oncol; 2003 Aug; 25(8):660-4. PubMed ID: 12902925
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immune thrombocytopenic purpura in adults in the last 10 years: single-centre experience.
    Pavkovic M; Trpkovska-Terzieva S; Sotirova T; Latifi A; Cevreska L; Stojanovic A
    Prilozi; 2012; 33(1):121-33. PubMed ID: 22952099
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of steroid and intravenous immunoglobulin on thrombopoietin levels in pediatric patients with immune thrombocytopenic purpura.
    Koçak U; Gürsel T; Oztürk G
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):121-5. PubMed ID: 10759004
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Appropriateness of intravenous immunoglobulin use in immune thrombocytopenia (ITP): A Canadian centre deep dive audit.
    Liu J; Pavenski K; Sholzberg M
    Transfus Apher Sci; 2019 Aug; 58(4):491-494. PubMed ID: 31105060
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety and Efficacy of Azathioprine as a Second Line Therapy for Primary Immune Thrombocytopenic Purpura.
    Poudyal BS; Sapkota B; Shrestha GS; Thapalia S; Gyawali B; Tuladhar S
    JNMA J Nepal Med Assoc; 2016; 55(203):16-21. PubMed ID: 27935917
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and Safety of a New 10% Intravenous Immunoglobulin Product in Patients with Primary Immune Thrombocytopenia (ITP).
    Hong J; Bang SM; Mun YC; Yhim HY; Lee J; Lim HS; Oh D;
    J Korean Med Sci; 2018 May; 33(19):e142. PubMed ID: 29736158
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immune thrombocytopenic purpura presenting in a patient after renal transplant for diabetic nephropathy.
    Rashid RM; Nabi Z; Ansari AZ; Qaiser QA
    BMC Nephrol; 2018 Mar; 19(1):69. PubMed ID: 29554892
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of adult idiopathic thrombocytopenic purpura.
    Nakhoul IN; Kozuch P; Varma M
    Clin Adv Hematol Oncol; 2006 Feb; 4(2):136-44, 153. PubMed ID: 16728922
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immune thrombocytopenia in the elderly: clinical course in 525 patients from a single center in China.
    Zhou H; Fu R; Wang H; Zhou F; Li H; Zhou Z; Zhang L; Yang R
    Ann Hematol; 2013 Jan; 92(1):79-87. PubMed ID: 22956151
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Major hemorrhage in children with idiopathic thrombocytopenic purpura: immediate response to therapy and long-term outcome.
    Medeiros D; Buchanan GR
    J Pediatr; 1998 Sep; 133(3):334-9. PubMed ID: 9738712
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Response to intravenous immunoglobulin predicts splenectomy response in children with immune thrombocytopenic purpura.
    Holt D; Brown J; Terrill K; Goldsby R; Meyers RL; Heximer J; Nordfors B; Slayton WB
    Pediatrics; 2003 Jan; 111(1):87-90. PubMed ID: 12509559
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura.
    Arnold DM; Nazi I; Santos A; Chan H; Heddle NM; Warkentin TE; Kelton JG
    Blood; 2010 Jan; 115(1):29-31. PubMed ID: 19897578
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Standard-dose intravenous anti-D immunoglobulin versus intravenous immunoglobulin in the treatment of newly diagnosed childhood primary immune thrombocytopenia.
    Papagianni A; Economou M; Tragiannidis A; Karatza E; Tsatra I; Gombakis N; Athanassiadou-Piperopoulou F; Athanasiou-Metaxa M
    J Pediatr Hematol Oncol; 2011 May; 33(4):265-9. PubMed ID: 21516022
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictors of chronic idiopathic thrombocytopenic purpura.
    ElAlfy M; Farid S; Abdel Maksoud A
    Pediatr Blood Cancer; 2010 Jul; 54(7):959-62. PubMed ID: 20405514
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intended management of children with acute idiopathic thrombocytopenic purpura: a national survey.
    Marks MK; Vadamalayan B; Ekert H; South MJ
    J Paediatr Child Health; 2005; 41(1-2):52-5. PubMed ID: 15670225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.